article thumbnail

Eli Lilly’s Zepbound Leads to Greater Weight Loss vs. Novo Nordisk Drug in Head-to-Head Test

MedCity News

The results could help Lilly differentiate its product from Novo Nordisk’s in the increasingly competitive market of obesity medications. The post Eli Lilly’s Zepbound Leads to Greater Weight Loss vs. Novo Nordisk Drug in Head-to-Head Test appeared first on MedCity News.

Leads 293
article thumbnail

Sanofi drops out of competitive breast cancer drug race after another trial failure

MedCity News

Sanofi breast cancer drug amcenestrant has failed in a Phase 3 clinical trial, leading the pharmaceutical giant to discontinue all clinical development of the small molecule. The move means Sanofi is out of the competitive chase to develop a so-called “oral SERD” therapy for patients with a certain type of breast cancer.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Will Walgreens’ Expansion into Specialty Pharmacy Affect the Industry?

MedCity News

They also think Walgreens’ move could lead to greater competition, consolidation and innovation within the broader pharmacy industry. Experts think that this move could yield several strategic benefits, given the higher profit margins associated with specialty medications compared to traditional drugs.

article thumbnail

Personalization In Sales Leads To Increased Loyalty and Repeat Business

Integrity Solutions

It provides competitive differentiation, nurtures customer relationships, helps them feel seen and heard , and ultimately leads to increased customer loyalty and repeat business. Always lead with compassion and empathy. The research also shows 61% of customers feel they’re treated as a number rather than a human being.

Sales 259
article thumbnail

How to Stay Competitive in the Evolving State of Martech

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks.

article thumbnail

J&J-Partnered Contineum Corrals $110M From IPO for Clinical Trials in Fibrosis & MS

MedCity News

Contineum Therapeutics plans to spend most of its IPO cash on clinical testing of a lead drug candidate in development for idiopathic pulmonary fibrosis and multiple sclerosis. This small molecule blocks a competitive target pursued by several other companies, including Bristol Myers Squibb and AbbVie.

article thumbnail

Leica, Philips come out on top in digital pathology systems market, KLAS finds

MedCity News

The imaging management systems made by Leica Biosystems and Philips seem to be leading the pack in this competitive market, according to a new report. The digital pathology market is poised for rapid growth in the U.S., with several vendors vying for dominance.

Marketing 273